Bruker releases preclinical MRI for neuroimaging
Bruker has released the BioSpec 150/11 system, an ultra-high-field MRI scanner for preclinical research for molecular and microscopic imaging.
Leveraging the concurrent development of Bruker's 15T MRI CryoProbe for neuroimaging, the BioSpec 150/11 system may allow for new research on in vivo molecular events, the company said.
The BioSpec 150/11 system is expected to be delivered to Vanderbilt University in Nashville, Tenn. this year. Scientists within the Vanderbilt University Institute of Imaging Science are planning to collaborate with Bruker to develop ultra-high-field MRI applications and techniques for molecular imaging studies in cancer biology, neuroscience and metabolism studies, and to advance translational imaging research that may benefit human clinical care.
Funds for the purchase of the 15T system were provided by the National Institutes of Health's National Center for Research Resources as part of its High-End Instrumentation program, funded in part by the American Recovery and Reinvestment Act.
Leveraging the concurrent development of Bruker's 15T MRI CryoProbe for neuroimaging, the BioSpec 150/11 system may allow for new research on in vivo molecular events, the company said.
The BioSpec 150/11 system is expected to be delivered to Vanderbilt University in Nashville, Tenn. this year. Scientists within the Vanderbilt University Institute of Imaging Science are planning to collaborate with Bruker to develop ultra-high-field MRI applications and techniques for molecular imaging studies in cancer biology, neuroscience and metabolism studies, and to advance translational imaging research that may benefit human clinical care.
Funds for the purchase of the 15T system were provided by the National Institutes of Health's National Center for Research Resources as part of its High-End Instrumentation program, funded in part by the American Recovery and Reinvestment Act.